glp 1 binge eating The rapid rise of GLP-1 receptor agonists presents a complex dilemma for clinicians managing patients with disorders. While these medications show potential in reducing eating behaviors by targeting brain reward The Ozempic Era and Eating
Description
Publisher'S Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
35% of users reported no side effects
The candidate is designed to induce weight loss while exploring beta-cell protection and kidney function improvement
Current results may have changed due to panel and methodology updates.
10.1111/dom.13162 3 ArthurJ
